Replimune Skin Cancer Therapy Fails Midstage Study Replimune Skin Cancer Therapy Fails Midstage Study

Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin cancer failed to significantly remove or reduce cancerous lesions in a midstage study.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news